"Quintiles leads the global CRO market having accrued a market share of 16.9% in 2007, equivalent to sales of $2.7bn...

MORE: Buy online now | Contents | Order form | Request brochure

Cost containment and regulatory pressures within the pharma industry are driving R&D outsourcing across the globe. Clinical obstacles to approval have become more significant due to the growing availability of existing generic treatments, and the trend to adopt Health Economics Outcomes Research (HEOR) assessments is increasing the complexity of clinical research. As a result, the scope of the CRO industry is expanding, and the global market is predicted to value $35bn by 2013.

'The Top 10 Contract Research Oraganizations' is a new report published by Business Insights that examines the competitive landscape of the global CRO industry. The latest key issues and evolving business models in the CRO market are identified and the leading companies in this sector are profiled in detail. For each of the top 10 CRO companies, this report provides a detailed examination of financial performance by business segment and growth strategies in the form of key acquisitions and divestments.

Understand the business strategies of the leading players in the rapidly growing market for contract research services with this report...

Top REASONS to buy this report today

• Compare the performances of the top 10 CRO companies across key business segments with this report’s analysis of Quintiles, Covance, Pharmal Product Development, Charles River Labs, ICON, Parexel, MDS, Kendle, PharmaNet Development and PRA International.

• Identify the market dynamics of the global CRO industry over the 2007-08 period, discover which emerging markets are becoming the CRO destinations of the future and understand the latest industrial trends across the UK, Japan, France, Germany, Italy, Spain and the US.

• Assess the future prospects of the top 10 CRO companies with this report’s analysis of each firm’s strengths, weaknesses, opportunities and threats, in addition to an examination of growth strategies via acquisitions and divestments.

• Measure the progress of other leading CRO companies by evaluating the financial performances of Aptuit, Life Sciences Research, Omnicare, SGS, CMIC, WuXi Pharmatech, Galapagos (Biofocus), LAB Research, United BioSource and Bio-Imaging.

How to order your copy today?

Download, complete, sign and return this order form via fax (+44 161 238 4141) or email (distribution@globalbusinessinsights.com). For any questions or assistance, please call us on +44 161 238 4045.